Advisory Services Network, LLC Acadia Pharmaceuticals Inc Transaction History

Advisory Services Network, LLC

  • $4.9 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$20.78 - $31.77 $124 - $190
6 New
6 $0
Q1 2021

May 24, 2021
SELL
$25.02 - $54.99 $625 - $1,374
-25 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$41.04 - $56.79 $1,026 - $1,419
25 New
25 $1,000
Q1 2020

May 15, 2020
SELL
$31.65 - $46.87 $52,159 - $77,241
-1,648 Closed
0 $0
Q4 2019

Feb 04, 2020
BUY
$36.21 - $51.4 $59,674 - $84,707
1,648 New
1,648 $71,000

Others Institutions Holding ACAD

# of Institutions
279
Shares Held
156M
Call Options Held
901K
Put Options Held
314K
View Full List

About ACADIA PHARMACEUTICALS INC

ACAD Quotes by TradingView
  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email